Startups
Syncona Limited
Frances House, PO Box273, Sir William Place, St Peter Port, Guernsey GY1 3RD
Syncona Limited is a Guernsey registered closed-ended investment company (registration55514) listed on the London Stock Exchange as SYNC. It began business as BACIT Limited on26October2012; inDecember2016 it acquired the original Wellcome-owned Syncona portfolio, changed its investment policy and adopted the Syncona name. The listed company supplies permanent capital to a life science company-building strategy, including neuroscience, retinal and central nervous system gene therapy and computational drug discovery businesses. It holds life science investments through corporate Syncona Holdings Limited and its capital pool through Syncona Investments LP Incorporated, of which it is sole limited partner. Separate English subsidiary Syncona Investment Management Limited10497864 is the regulated alternative investment fund manager and houses the manager staff; they are not represented here as listed-company employees. The listed company’s six current directors are Melanie Gee, Kemal Malik, Julie Cherrington, Norman Crighton, Gian Piero Reverberi and John Roche. Genuine historical cash capital raised was GBP206734775 at the2012IPO, GBP200M at the2013C-share listing, and GBP169581708 inDecember2016. The latter excludes portfolio assets exchanged for shares. Share prices, NAV, portfolio values and investment commitments are not treated as cash financing or external LP fund closes.
Founded 2012
Team
 Gian Piero ReverberiNon-Executive Director |
 John RocheNon-Executive Director |
 Julie CherringtonNon-Executive Director |
 Kemal MalikSenior Independent Director |
 Melanie GeeChair |
 Norman CrightonNon-Executive Director |